The Peptide Revolution: Therapeutic Potential and Market Growth

Ongoing research is expected to lead to the development of new peptide-based drugs targeting a wider range of diseases. Advancements in oral peptide delivery, making these therapies more convenient for patients, are also on the horizon. With over 80 approved peptide drugs currently on the market and hundreds more in various stages of clinical trials, peptides are solidifying their position as a significant class of pharmaceuticals. You can learn more about peptide drug discovery in  our latest webinar  from peptide experts Dr Peter Timmerman and Dr Sangram Kale.